Andere talen PreveCeutical Medical Inc. Deutsche Boerse AG

Aandelen

18H

CA74141E1043

Vertraagde tijd Deutsche Boerse AG Andere beurzen 08:12:29 17-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,01 ^EUR	0,00%		0,00%	-28,57%

05/07	PreveCeutical Medical Inc. rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
28/06	PreveCeutical Medical Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Preveceutical Announces Revocation of Management Cease Trade Order	09/07
PreveCeutical Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05/07
PreveCeutical Provides Update on Management Cease Trade Order	29/06
PreveCeutical Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/06
PreveCeutical Medical Inc. Enters into Series of Unsecured, Non-Convertible and Interest-Free Loan Agreements	17/06
PreveCeutical Enters into Loan Agreements	17/06
PreveCeutical Provides Update on Management Cease Trade Order	14/06
PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence	06/06
Preveceutical Provides Update on Management Cease Trade Order	30/05
Preveceutical Announces First Tranche Closing of Private Placement	30/05
PreveCeutical Medical : Announces First Tranche Closing of Private Placement	30/05
PreveCeutical Provides Update on Management Cease Trade Order	17/05
PreveCeutical Announces Management Cease Trade Order	03/05
PreveCeutical Medical Inc. announced that it expects to receive CAD 0.25 million in funding	02/05
PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program	04/12
PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program	04/12
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11
PreveCeutical & Endosane Announce Update on Intranasal CBD Application	18-09-23
PreveCeutical Medical Inc. and Endosane Pharmaceuticals GmbH Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD and Pharmacologically Relevant Doses Following Intranasal CBD Application	18-09-23
PreveCeutical Medical Inc. Showcases Dynamic Evolution in AI Strategy	12-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen PreveCeutical Medical Inc. Deutsche Boerse AG

Aandelen

18H

CA74141E1043

Andere talen

Filters